Cargando…

Current new challenges in the management of ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory condition of the gastrointestinal tract. Although the cause of UC is postulated to be multifactorial in nature, including genetic predisposition, epithelial barrier defects, dysregulation of immune responses, and environmental factors, the specific p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Tomohiro, Naganuma, Makoto, Kanai, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361009/ https://www.ncbi.nlm.nih.gov/pubmed/30678445 http://dx.doi.org/10.5217/ir.2018.00126

Ejemplares similares

The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry
por: Fukuda, Tomohiro, et al.
Publicado: (2017)

Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis
por: Naganuma, Makoto
Publicado: (2020)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Current approaches to the management of new-onset ulcerative colitis
por: Marchioni Beery, Renée, et al.
Publicado: (2014)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
por: Mizuno, Shinta, et al.
Publicado: (2020)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels
por: Naganuma, Makoto, et al.
Publicado: (2017)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

Demarcated redness associated with increased vascular density/size: a useful marker of flat-type dysplasia in patients with ulcerative colitis
por: Ikebata, Akiyoshi, et al.
Publicado: (2021)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission
por: Hisamatsu, Tadakazu, et al.
Publicado: (2015)

Subepithelial Lesion-like Carcinoma Occurred in Ulcerative Colitis
por: Takabayashi, Kaoru, et al.
Publicado: (2023)

Current and Emerging Biologics for Ulcerative Colitis
por: Park, Sung Chul, et al.
Publicado: (2015)

Ulcerative Colitis: A Challenge to Surgeons
por: Parray, Fazl Q, et al.
Publicado: (2012)

Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions
por: Holvoet, Tom, et al.
Publicado: (2021)

What strategies do ulcerative colitis patients employ to facilitate adherence?
por: Kawakami, Aki, et al.
Publicado: (2017)

Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
por: Mizuno, Shinta, et al.
Publicado: (2017)

Correction to: Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Ulcerative Colitis: Current and Emerging Treatment Strategies
por: Kayal, Maia, et al.
Publicado: (2019)

Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
por: Naganuma, Makoto, et al.
Publicado: (2019)

Recent trends in diagnostic techniques for inflammatory bowel disease
por: Naganuma, Makoto, et al.
Publicado: (2015)

An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022)

Old but Fancy: Curcumin in Ulcerative Colitis—Current Overview
por: Pituch-Zdanowska, Aleksandra, et al.
Publicado: (2022)

New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
por: Tripathi, Kartikeya, et al.
Publicado: (2019)

Cytomegalovirus colitis with a new diagnosis of ulcerative colitis in an elderly woman
por: Ihara, Kousuke, et al.
Publicado: (2022)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Optimal management of steroid-dependent ulcerative colitis
por: Khan, Hafiz M Waqas, et al.
Publicado: (2015)

Second Korean guidelines for the management of ulcerative colitis
por: Choi, Chang Hwan, et al.
Publicado: (2017)

A review of the therapeutic management of ulcerative colitis
por: Aslam, Nasar, et al.
Publicado: (2022)

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023)

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice
por: Masuda, Masataka, et al.
Publicado: (2022)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

ULCERATIVE COLITIS
Publicado: (1969)

Patient considerations in the management of ulcerative colitis – role of vedolizumab
por: Kothari, Megha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cu3odgptqkmebfp8pld7l8n3md